Company intelligence / Profile preview

Wired Biopharm

Shanghai, Shanghai, China
Ownership
Private
Employees
~50
Development stage
Other
01

Overview

Wired Biopharm (operated by Wired Global Holding) is a clinical-stage biotechnology company focused on developing next-generation multi-specific antibodies and antibody-drug conjugates (ADCs) for oncology and immunology. Founded in 2021 by industry veteran Dr. Wei-Dong Jiang, the company leverages its proprietary platform technology to engineer biologics with enhanced therapeutic indices and improved safety profiles. Its lead program, WBD-101, is a bispecific antibody targeting GPC3 and CD3 currently undergoing Phase 1 clinical evaluation for hepatocellular carcinoma. The company maintains dual operations in Shanghai and California to bridge global innovation and manufacturing. Wired Biopharm is backed by top-tier investors including Lilly Asia Ventures and IDG Capital to advance its diverse pipeline of precision medicines.

Therapeutic areas
Oncology
Modalities
Bispecific monoclonal antibodyAntibody-drug conjugateMonoclonal antibody
Industry
Biotech

Beyond the preview

Go deeper on Wired Biopharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Full profile access

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Full profile access

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Full profile access

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Full profile access

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Full profile access

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Wired Biopharm.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call